|
Real-time Estimate
Cboe BZX
10:43:14 24/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 34.52 USD | -0.65% |
|
+0.10% | +12.24% |
| 05:27pm | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| 10:37am | Hansa Biopharma brings in two new board members | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.42TCr | |||||
| 5.96TCr | |||||
| 2.58TCr | - | ||||
| 2.47TCr | - | ||||
| 2.09TCr |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
